Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injuryNEURAL REGENERATION RESEARCHIF6.72022-01-0113OAAI
未登录.png){kind=icon}
未登录
